Extract
Ablexis Appoints R. Scott Greer Chairman of the Board and Richard Hoffman Chief Business Officer.
Expanding Senior Management Team Supports Next-Generation Platform for Antibody Drug Discovery
SAN FRANCISCO -- Ablexis, LLC, a biotechnology company dedicated to developing the AlivaMab Mouse, an innovative next-generation platform for antibody drug...See the full content of this document
Sponsored links
